Endometriosis is a chronic and progressive disease manifested by chronic pelvic pain and infertility and which may affect 2–10% of women of reproductive age. Because it is an oestrogen-dependent disease, the goal of current medical therapy is to induce hypoestrogenism or to antagonise oestrogen action. Oestrogen biosynthesis in women of reproductive age takes place primarily in the ovary, while after spontaneous or surgical menopause, the adipose tissue and adrenal glands are the main source.1 Aromatase P450 catalyses the conversion of androstenedione of adrenal origin to oestrogens, endometriotic tissues express it2–4 and prostaglandins are the most potent known aromatase stimulator in endometriotic stromal cells.

Razzi, S., Fava, A., Sartini, A., DE SIMONE, S., Cobellis, L., & Petraglia, F. (2004). Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 111(2), 182-184 [10.1046/j.1471-0528.2003.00038.x].

Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman

FAVA, A.;PETRAGLIA, F.
2004

Abstract

Endometriosis is a chronic and progressive disease manifested by chronic pelvic pain and infertility and which may affect 2–10% of women of reproductive age. Because it is an oestrogen-dependent disease, the goal of current medical therapy is to induce hypoestrogenism or to antagonise oestrogen action. Oestrogen biosynthesis in women of reproductive age takes place primarily in the ovary, while after spontaneous or surgical menopause, the adipose tissue and adrenal glands are the main source.1 Aromatase P450 catalyses the conversion of androstenedione of adrenal origin to oestrogens, endometriotic tissues express it2–4 and prostaglandins are the most potent known aromatase stimulator in endometriotic stromal cells.
Razzi, S., Fava, A., Sartini, A., DE SIMONE, S., Cobellis, L., & Petraglia, F. (2004). Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 111(2), 182-184 [10.1046/j.1471-0528.2003.00038.x].
File in questo prodotto:
File Dimensione Formato  
Treatment of severe.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 93.91 kB
Formato Adobe PDF
93.91 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11365/26691
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo